In the present study, we confirmed a potential myeloproliferative role of NLRP3 by demonstrating that the expression of NLRP3 and the NLRP3 inflammasome-related genes ASC, IL1B, and IL18 is increased in AML patient cells compared to cells from healthy donors. This evidence concerns the gene IL18 and acute myeloid leukemia.